These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16633158

  • 1. Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam: a case series.
    Bona JR.
    J Clin Psychopharmacol; 2006 Apr; 26(2):215-6. PubMed ID: 16633158
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
    Chen PH, Liu HC.
    J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia].
    Lambert PA, Wolff P, de Maximy B, Ghenim A.
    Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832
    [No Abstract] [Full Text] [Related]

  • 7. Levetiracetam as a treatment for tardive dyskinesia: a case report.
    McGavin CL, John V, Musser WS.
    Neurology; 2003 Aug 12; 61(3):419. PubMed ID: 12913217
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.
    Tousi B, Subramanian T.
    Parkinsonism Relat Disord; 2005 Aug 12; 11(5):333-4. PubMed ID: 15949966
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):761-4. PubMed ID: 18201810
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE, Povlsen UJ, Meidahl B, Gerlach J.
    Psychopharmacol Bull; 1986 Apr 01; 22(1):250-3. PubMed ID: 2873612
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia.
    Lyons KE, Pahwa R.
    Clin Neuropharmacol; 2006 Apr 01; 29(3):148-53. PubMed ID: 16772814
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.